ACT EU aims to provide a training curriculum informed by regulatory experience, with modules on drug development and regulatory science.
This curriculum is expected to engage universities and micro, small and medium-sized enterprises (SMEs), and serve as an educational ecosystem.
Survey on clinical trials training needs of academia and SMEs
Stakeholders from academia or SMEs involved in the development of medicines for human use are invited to share their clinical trial training needs via the open survey by 11 February 2025.
The identified training needs may also highlight potential gaps. An overview will be published later in 2025.
Survey of academia and SME training needs
Related documents
A training strategy is available, setting out high-level objectives for the development of a training curriculum. The document highlights the importance of accessing appropriate expertise in medicines development.
A summary of the gap analysis on training needs of regulators involved in clinical trial assessment is also available.
